Latest Elypta News & Updates
See the latest news and media coverage for Elypta. We track all announcements, press releases, and industry mentions in real time, all in one place.
Metabolism-based liquid biopsy company
elypta.com- Headquarters
- Solna, Sweden
- Founded year
- 2017
- Company type
- Private company
- Number of employees
- 30–50
Last updated
Latest news about Elypta
In short: Elypta advanced its metabolism-based liquid biopsy platform for early cancer detection through clinical studies, funding, and board appointments.
Company announcements
-
Elypta is nominated for Medtech of the Year
The nomination recognizes Elypta's work in enabling earlier cancer detection, with Karl Bergman set to attend LSX in London in November.
-
Elypta welcomes three new team members
Andrea Boman joins as QA Manager, Flavia Plastino as Research Engineer, and Maria Aspenberg as QC Engineer, all with strong biomedical backgrounds.
-
Elypta is hiring a quality control engineer
The role focuses on enabling earlier detection of cancer. Interested candidates can find application details through the provided link.
-
Elypta is hiring a research and production engineer
The role focuses on advancing early cancer detection. Application details are available via the provided link.
Media coverage
-
Elypta Raises ?6 Million in a Late Seed Round Led by Industrifonden
STOCKHOLM, Jan. 23, 2020 /PRNewswire/ -- Elypta, the Swedish molecular diagnostics firm pioneering metabolism-based liquid biopsies, has raised ?6.1 million in a late seed funding...
-
€13.6 million funding for early detection of Lynch syndrome cancers | Tampere universities
In addition to clinical work, the ... new innovations. The consortium’s sub-projects collaborate with promising biomarker companies like MSInsight and Elypta, providing a multi-level approach...
-
LSX Roundup: Startups Elypta, QuantiLight And Plexaa Debut New Tech
Back-to-back meetings at LSX? No time to attend the innovator showcase? Here is what you might have missed from medtech innovators at the LSX World...
-
Urine test could halve post-op scans for kidney cancer
A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access...
Track Elypta and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Macronix
Winbond
Quantum Traffic
Street Smart
GTM
Right Traffic
TMI
Core Highways
Helix Traffic Solutions
RoadSafe
Valtir
AWP Safety
RentSafe
HW Martin
Saferoad
Colorado Barricade
Moeris
BUKO
Antero Resources
ProPetro
Marvel Fusion
Energy Transfer
First Commonwealth Bank
Planet Fitness
Interlink Electronics
Strategy
AST SpaceMobile
Permian Resources
Coherent
enCore Energy
Fastly
Amprius Technologies
Red Cat
W&T Offshore
Wheels Up
SoundHound AI